Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay.
نویسندگان
چکیده
Alice Huertas, Frédéric Perros, Ly Tu, Sylvia Cohen-Kaminsky, David Montani, Peter A Complex Interplay Immune Dysregulation and Endothelial Dysfunction in Pulmonary Arterial Hypertension: Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2014 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/CIRCULATIONAHA.113.004555 2014;129:1332-1340 Circulation. http://circ.ahajournals.org/content/129/12/1332 World Wide Web at: The online version of this article, along with updated information and services, is located on the
منابع مشابه
Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)
Endothelial dysfunction is a major player in the development and progression of vascular pathology in pulmonary arterial hypertension (PAH), a disease associated with small vessel loss and obstructive vasculopathy that leads to increased pulmonary vascular resistance, subsequent right heart failure, and premature death. Over the past ten years, there has been tremendous progress in our understa...
متن کاملRNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.
RATIONALE Pulmonary arterial hypertension is characterized by endothelial dysregulation, but global changes in gene expression have not been related to perturbations in function. OBJECTIVES RNA sequencing was used to discriminate changes in transcriptomes of endothelial cells cultured from lungs of patients with idiopathic pulmonary arterial hypertension versus control subjects and to assess ...
متن کاملCALL FOR PAPERS Biomarkers in Lung Diseases: from Pathogenesis to Prediction to New Therapies Suppression of endothelial PGC-1 is associated with hypoxia-induced endothelial dysfunction and provides a new therapeutic target in pulmonary arterial hypertension
Ye JX, Wang SS, Ge M, Wang DJ. Suppression of endothelial PGC-1 is associated with hypoxia-induced endothelial dysfunction and provides a new therapeutic target in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 310: L1233–L1242, 2016. First published April 15, 2016; doi:10.1152/ajplung.00356.2015.— Endothelial dysfunction plays a principal role in the pathogenesis of pulmon...
متن کاملHemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
Pulmonary hypertension is a highly prevalent complication of sickle cell disease and is a strong risk factor for early mortality. However, the pathophysiologic mechanisms leading to pulmonary vasculopathy remain unclear. Transgenic mice provide opportunities for mechanistic studies of vascular pathophysiology in an animal model. By microcardiac catheterization, all mice expressing exclusively h...
متن کاملFenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells
Fenfluramine is prescribed either alone or in combination with phentermine as part of Fen-Phen, an anti-obesity medication. Fenfluramine was withdrawn from the US market in 1997 due to reports of heart valvular disease, pulmonary arterial hypertension, and cardiac fibrosis. Particularly, idiopathic pulmonary arterial hypertension (IPAH), previously referred to as primary pulmonary hypertension ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation
دوره 129 12 شماره
صفحات -
تاریخ انتشار 2014